Showing results (1591-1600 of 37,639) with videos related to
Sort By:
Pageof 3,764
Cancers|September 1, 2019
Novel Human Bispecific Aptamer-Antibody Conjugates for Efficient Cancer Cell KillingMargherita Passariello, Simona Camorani, Cinzia Vetrei, et al.Cancers|September 1, 2019
Plasma Biomarkers and Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer: New Tools for Better Patient Selection?Adrien Costantini, Paul Takam Kamga, Coraline Dumenil, et al.Cancers|September 5, 2019
Etiology-Specific Analysis of Hepatocellular Carcinoma Transcriptome Reveals Genetic Dysregulation in Pathways Implicated in Immunotherapy EfficacyWei Tse Li, Angela E Zou, Christine O Honda, et al.Cancers|September 5, 2019
Ultra-Mutation in IDH Wild-Type Glioblastomas of Patients Younger than 55 Years is Associated with Defective Mismatch Repair, Microsatellite Instability, and Giant Cell EnrichmentValeria Barresi, Michele Simbolo, Andrea Mafficini, et al.Cancers|September 5, 2019
STAT3, a Master Regulator of Anti-Tumor Immune ResponseCédric Rébé, François GhiringhelliCancers|September 5, 2019
Unique Aberrations in Intimal Sarcoma Identified by Next-Generation Sequencing as Potential Therapy TargetsJason Roszik, Abir Khan, Anthony P Conley, et al.Cancers|September 5, 2019
FAK-Copy-Gain Is a Predictive Marker for Sensitivity to FAK Inhibition in Breast CancerYoung-Ho Kim, Hyun-Kyoung Kim, Hee Yeon Kim, et al.Cancers|September 5, 2019
Radiation-Induced Thyroid Cancers: Overview of Molecular SignaturesKeiji Suzuki, Vladimir Saenko, Shunichi Yamashita, et al.Cancers|August 24, 2019
ADAM17: An Emerging Therapeutic Target for Lung CancerMohamed I Saad, Stefan Rose-John, Brendan J JenkinsCancers|August 24, 2019
Hyper-Activation of STAT3 Sustains Progression of Non-Papillary Basal-Type Bladder Cancer via FOSL1 RegulomeLuisa Benerini Gatta, Laura Melocchi, Mattia Bugatti, et al.Pageof 3,764